Nuclear Medicine Market is witnessing growth CAGR of 13.0% by 2030 due to the presence of a robust product pipeline
Nuclear Medicine Industry Overview The global nuclear medicine marke t size is expected to reach USD 24.4 billion by 2030, expanding at a CAGR of 13.0% from 2022 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic diseases such as cancer & thyroid is anticipated to drive market growth. The impending approval of multiple radiopharmaceutical therapeutics during the forecast period will be a major driver for the market. For instance, in March 2022, Novartis AG received approval for Pluvicto (Lu 177) for the treatment of adult patients with prostate cancer . Nuclear Medicine Market Segmentation Grand View Research has segmented the global nuclear medicine market based on product type, application, and region: Based on the Product Type Insights, the market is segmented into Diagnostic products and Therapeutic Products. The diagnostic product segment held the highest market share in 2021 owing ...